M.M. Dillon & Co. M.M. Dillon & Co. M.M. Dillon & Co. M.M. Dillon & Co.
  • Why Us
  • Deals
  • Team
  • Presentation
  • Media
  • Services
  • History
  • Contact
M.M. Dillon & Co. M.M. Dillon & Co.
  • Why Us
  • Deals
  • Team
  • Presentation
  • Media
  • Services
  • History
  • Contact

M.M. DILLON & CO SERVES AS A FINANCIAL ADVISOR TO CARDAX IN ITS EXCHANGE OFFER FOR WARRANTS AND CONVERSION TO COMMON STOCK

M.M. Dillon & Co acted as a financial advisor to Cardax Inc (OTC CDXI ) in its registered public exchange offer for 27.5 million warrants into newly issued warrants and…

M.M. DILLON & CO SERVES AS A FINANCIAL ADVISOR TO WINDSTREAM COMMUNICATIONS IN ITS SPIN OFF OF UNITI AND RELATED EXCHANGE OFFER FOR DEBT

M.M. Dillon acted as an advisor to Windstream Communications (NYSE WIN) in the contested spin off and related debt exchange for $542 million working with company counsel Kirkland & Ellis.…

M.M DILLON & CO SERVES AS FINANCIAL ADVISOR TO CAREDX INC IN ITS ACQUISITION OF ALLENEX AB

MM Dillon acted as an advisor to CareDx, Inc. (Nasdaq:CDNA) the completion of its previously announced acquisition of publically traded Allenex AB. The acquisition included a successful tender of 98.37%…

M.M DILLON & CO SERVES AS FINANCIAL ADVISOR TO POLARIOD IN BANKRUPTCY

MM Dillon was retained by Boies, Schiller & Flexner LLP as a financial consultant for the benefit of their clients, Douglas A. Kelley, Trustee et al (the “Trustees”) of the…

M.M DILLON & CO SERVES AS FINANCIAL ADVISOR TO CONTRAFECT CORPORATION IN ITS UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND WARRANTS

MM Dillon acted as a financial advisor to ContraFect Corporation (CFRX), in its underwritten public offering of 32,000,000 shares of its common stock and related warrants to purchase 16,000,000 shares…

M.M DILLON & CO SERVES AS SOLE FINANCIAL ADVISOR TO QUANTASOL IN ITS ACQUISITION BY JDSU

M.M. Dillon & Company (“Dillon”) acted as sole financial advisor to QuantaSol Ltd. In its sale to JDSU (NASDAQ: JDSU). JDSU is now Viavi Solutions. Terms of the transaction were…

M.M DILLON & CO SERVES AS FINANCIAL ADVISOR TO INOVIO IN THE SPIN OFF OF GENEOS THERAPEUTICS, INC

MM Dillon advised Inovio in the spin-off of GENEOS Therapeutics, Inc., to develop and commercialize neo-antigen based personalized cancer therapies. While Inovio pursues the unique potential of its SynCon® immunotherapy…

M.M. DILLON & CO. ADVISES MOLECULAR INSIGHT CHAPTER 11 BANKRUPTCY

CRT Investment Banking LLC n/k/a M.M. Dillon & Co. served as financial advisor and expert witness to Molecular Insight Pharmaceuticals, Inc. in connection with the Company’s chapter 11 bankruptcy in…

M.M. DILLON & CO. SERVES AS PRIVATE PLACEMENT AGENT IN CELL THERAPEUTICS, INC COVERTIBLE NOTE FINANCING

Cell Therapeutics, Inc. (“Cell Therapeutics” or the “Company”) engaged M.M. Dillon & Co. (“Dillon”) to privately place $82,000,000 of 5 year, 6.75% Convertible Senior Notes. The notes were issued under…

M.M DILLON & CO SERVES AS FINANCIAL ADVISOR TO MINORITY SHAREHOLDERS OF TEXAS SPINE & JOINT HOSPITAL IN JOINT VENTURE WITH UNITED SURGICAL PARTNERS

MM Dillon advised the minority shareholders of Texas Spine & Joint Hospital (TSJH) which has partnered with Baylor Scott & White Health (BSWH) and United Surgical Partners International (USPI). MM…
  • 1
  • 2
  • 3
  • ...
  • 9

Next Page »

Categories

  • Financings
  • M&A
  • News
  • Restructuring
© 2018 M.M. Dillon & Co. - All Rights Reserved
  • FINRA
  • SIPC
  • FINRA BROKER CHECK
  • DISCLOSURES